BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8006495)

  • 1. Noninvasive carcinoma of the breast: the rationale for various treatment options.
    Kuske RR
    J La State Med Soc; 1994 Apr; 146(4):128-32. PubMed ID: 8006495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management of noninvasive (in situ) breast cancer.
    Silverstein MJ
    Adv Surg; 2000; 34():17-41. PubMed ID: 10997214
    [No Abstract]   [Full Text] [Related]  

  • 3. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.
    Fisher B; Costantino J; Redmond C; Fisher E; Margolese R; Dimitrov N; Wolmark N; Wickerham DL; Deutsch M; Ore L
    N Engl J Med; 1993 Jun; 328(22):1581-6. PubMed ID: 8292119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The problem of ductal carcinoma in situ of the breast.
    Fentiman IS
    Ann Chir Gynaecol; 1992; 81(4):334-6. PubMed ID: 1336650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis and treatment of breast cancer.
    Matory YL
    Curr Opin Gen Surg; 1994; ():217-23. PubMed ID: 7583973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome.
    Bradley SJ; Weaver DW; Bouwman DL
    Am Surg; 1990 Jul; 56(7):428-32. PubMed ID: 2164336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of intraductal breast cancer--noncomedo type.
    Griffin A; Frazee RC
    Am Surg; 1993 Feb; 59(2):106-9. PubMed ID: 8386487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis.
    Ben-David MA; Kleer CG; Paramagul C; Griffith KA; Pierce LJ
    Cancer; 2006 Jan; 106(1):28-34. PubMed ID: 16329136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
    Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
    Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
    Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
    Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unresolved questions in the indications for the conservative treatment of invasive cancer of the breast].
    Zinzindohoué C; Bobin JY
    Bull Cancer; 1998 Sep; 85(9):763-72. PubMed ID: 9817060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
    Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Controversies in breast conservation treatment for breast cancer].
    Motomura K; Egawa C; Komoike Y; Inaji H; Koyama H
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):168-75. PubMed ID: 14997746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of in situ cancer.
    Recht A; Connolly JL; Schnitt SJ; Harris JR
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):691-708. PubMed ID: 2558105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lobular carcinoma in situ as a component of breast cancer points to no contraindication for breast-conserving therapy].
    Sautter-Bihl ML
    Strahlenther Onkol; 2001 Jan; 177(1):51-2. PubMed ID: 11200114
    [No Abstract]   [Full Text] [Related]  

  • 18. [Conservative treatment of sub-clinical noninfiltrating cancers of the breast (102 EOA in situ, TONO)].
    Brandone H; Ayme Y; Hans D; Dubau A; Brandone JM; Robert F; Pollet JF; Amalric F; Bressac C; Jacquemier J
    Ann Chir; 1995; 49(1):56-61. PubMed ID: 7741470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conservative surgery for ductal carcinoma in situ of the breast].
    Tersigni R; Mencacci R; Alessandroni L; Baiano G; Mardarella C; Parisi A
    Minerva Chir; 2003 Aug; 58(4):563-9. PubMed ID: 14603170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection criteria for breast conservation in breast cancer.
    Sakorafas GH; Tsiotou AG
    Eur J Surg; 2000 Nov; 166(11):835-46. PubMed ID: 11097148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.